Marc Martinell
University of Barcelona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marc Martinell.
British Journal of Pharmacology | 2000
Beatriz Montaner; Sira Navarro; Maria Piqué; Marta Vilaseca; Marc Martinell; Ernest Giralt; Joan Gil; Ricardo Pérez-Tomás
The effects of supernatant from the bacterial strain Serratia marcescens 2170 (CS‐2170) on the viability of different haematopoietic cancer cell lines (Jurkat, NSO, HL‐60 and Ramos) and nonmalignant cells (NIH‐3T3 and MDCK) was studied. We examined whether this cytotoxic effect was due to apoptosis, and we purified the molecule responsible for this effect and determined its chemical structure. Using an MTT assay we showed a rapid (4 h) decrease in the number of viable cells. This cytotoxic effect was due to apoptosis, according to the fragmentation pattern of DNA, Hoechst 33342 staining and FACS analysis of the phosphatidylserine externalization. This apoptosis was blocked by using the caspase inhibitor Z‐VAD.fmk, indicating the involvement of caspases. Prodigiosin is a red pigment produced by various bacteria including S. marcescens. Using mutants of S. marcescens (OF, WF and 933) that do not synthesize prodigiosin, we further showed that prodigiosin is involved in this apoptosis. This evidence was corroborated by spectroscopic analysis of prodigiosin isolated from S. marcescens. These results indicate that prodigiosin, an immunosuppressor, induces apoptosis in haematopoietic cancer cells with no marked toxicity in nonmalignant cells, raising the possibility of its therapeutic use as an antineoplastic drug.
Journal of Computer-aided Molecular Design | 2005
Ignasi Belda; Sergio Madurga; Xavier Llorà; Marc Martinell; Teresa Tarragó; Mireia Piqueras; Ernesto Nicolás; Ernest Giralt
SummaryOne of the goals of computational chemists is to automate the de novo design of bioactive molecules. Despite significant advances in computational approaches to ligand design and binding energy evaluation, novel procedures for ligand design are required. Evolutionary computation provides a new approach to this design endeavor. We propose an evolutionary tool for de novo peptide design, based on the evaluation of energies for peptide binding to a user-defined protein surface patch. Special emphasis has been placed on the evaluation of the proposed peptides, leading to two different evaluation heuristics. The software developed was successfully tested on the design of ligands for the proteins prolyl oligopeptidase, p53, and DNA gyrase.
ChemBioChem | 2006
Marc Martinell; Xavier Salvatella; Jimena Fernández‐Carneado; Susana Gordo; Miguel Feliz; Margarita Menéndez; Ernest Giralt
The applied interaction of synthetic molecules with defined regions of protein surfaces is an emerging strategy for the modulation of protein activity and/or stability. In spite of recent advances, the design of these molecules is not trivial. Among the most challenging aspects in designing these compounds is that they must compete with water molecules for interaction with polar patches of protein surfaces. Herein is reported the preparation of an arginine‐rich peptide that interacts in aqueous solution with a very hydrophilic patch at the surface of the tetramerization domain of the tumor suppressor protein p53. The interaction has been studied by several complementary techniques. By using this peptide as a template, a library of peptides has been prepared and evaluated in order to examine the different factors that contribute to the recognition event. The conclusions extracted from this work could be useful for the design of ligands directed at highly hydrophilic protein surface patches.
BMC Structural Biology | 2004
Helena Mira; Marçal Vilar; Vicent Esteve; Marc Martinell; Marcelo J. Kogan; Ernest Giralt; David Salom; Ismael Mingarro; Lola Peñarrubia; Enrique Pérez-Payá
BackgroundArabidopsis thaliana copper metallochaperone CCH is a functional homologue of yeast antioxidant ATX1, involved in cytosolic copper transport. In higher plants, CCH has to be transported to specialised cells through plasmodesmata, being the only metallochaperone reported to date that leaves the cell where it is synthesised. CCH has two different domains, the N-terminal domain conserved among other copper-metallochaperones and a C-terminal domain absent in all the identified non-plant metallochaperones. The aim of the present study was the biochemical and biophysical characterisation of the C-terminal domain of the copper metallochaperone CCH.ResultsThe conformational behaviour of the isolated C-domain in solution is complex and implies the adoption of mixed conformations in different environments. The ionic self-complementary peptide KTEAETKTEAKVDAKADVE, derived from the C-domain of CCH, adopts and extended conformation in solution with a high content in β-sheet structure that induces a pH-dependent fibril formation. Freeze drying electron microscopy studies revealed the existence of well ordered amyloid-like fibrils in preparations from both the C-domain and its derivative peptide.ConclusionA number of proteins related with copper homeostasis have a high tendency to form fibrils. The determinants for fibril formation, as well as the possible physiological role are not fully understood. Here we show that the plant exclusive C-domain of the copper metallochaperone CCH has conformational plasticity and forms fibrils at defined experimental conditions. The putative influence of these properties with plant copper delivery will be addressed in the future.
genetic and evolutionary computation conference | 2004
Ignasi Belda; Xavier Llorà; Marc Martinell; Teresa Tarragó; Ernest Giralt
One of the goals of computational chemistry is the automated de novo design of bioactive molecules. Despite significant progress in computational approaches to ligand design and efficient evaluation of binding energy, novel procedures for ligand design are required. Evolutionary computation provides a new approach to this design issue. A reliable framework for obtaining ligands via evolutionary algorithms has been implemented. It provides an automatic tool for peptide de novo design, based on protein surface patches defined by user. A special emphasis has been given to the evaluation of the proposed peptides. Hence, we have devised two different evaluation heuristics to carry out this task. Then, we have tested the proposed framework in the design of ligands for the protein Prolyl oligopetidase, p53, and DNA Gyrase.
Toxicological Sciences | 2005
Beatriz Montaner; Wilmar Castillo-Ávila; Marc Martinell; Rupert Öllinger; Joan Aymamí; Ernest Giralt; Ricardo Pérez-Tomás
Angewandte Chemie | 2004
Xavier Salvatella; Marc Martinell; Margarida Gairí; Mauricio G. Mateu; Miguel Feliz; Andrew D. Hamilton; Javier de Mendoza; Ernest Giralt
Biochemical Pharmacology | 2005
Vanessa Soto-Cerrato; Beatriz Montaner; Marc Martinell; Marta Vilaseca; Ernest Giralt; Ricardo Pérez-Tomás
International Journal of Peptide Research and Therapeutics | 2007
Meritxell Teixidó; Josep Maria Caba; Roger Prades; Esther Zurita; Marc Martinell; Marta Vilaseca; Fernando Albericio; Ernest Giralt
Molecular Genetics and Metabolism | 2017
Richard Roberts; Laura Rodríguez-Pascau; Ana Maria Garcia; Elena Cubero; Pilar Pizcueta; Aida Delgado; Marc Revés; Natalia Pérez; Ana Ruano; Joan Aymamí; Katsumi Higaki; Daniel Grinberg; Lluïsa Vilageliu; Marc Martinell; Xavier Barril